Micronesia (country) vs Panama: Immunization, Hib3 (% of children ages 12-23 months)
Micronesia (country)
71.0%
in 2024
Panama
72.0%
in 2024
Micronesia (country) rank
162nd
Panama rank
160th
Immunization, Hib3 (% of children ages 12-23 months) over time
- Micronesia (country)
- Panama
How they compare
Panama currently reports 72.0% against 71.0% in Micronesia (country), a difference of 1.0%.
Across all 24 years both countries report, Panama has been ahead every year.
Micronesia (country) ranks 162nd and Panama ranks 160th of 191 countries.
Panama has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Micronesia (country) | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.4% | 91.9% | 21.4% | Panama |
| 2010s | 61.5% | 84.2% | 22.7% | Panama |
| 2020s | 63.2% | 77.2% | 14.0% | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Micronesia (country) or Panama?
- Panama, at 72.0% against 71.0% in Micronesia (country) as of 2024.
- What is the difference in immunization, hib3 between Micronesia (country) and Panama?
- 1.0%, with Panama ahead.
- How many years of comparable data are there for Micronesia (country) and Panama?
- 24 years are reported by both, from 2001 to 2024.
- How do Micronesia (country) and Panama rank globally for immunization, hib3?
- Micronesia (country) ranks 162nd and Panama ranks 160th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.